Grupo de Neurobioloxia Molecular e Celular da Enfermidade de Parkinson
Parkinson neurobiol
![Foto de Grupo de Neurobioloxia Molecular e Celular da Enfermidade de Parkinson](/img/grupo.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (6)
2022
-
Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy
Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273
-
Cardiac amyloidosis: Description of a series of 143 cases
Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213
-
Correlation between Blunted Nocturnal Decrease in Diastolic Blood Pressure and Oxidative Stress: An Observational Study
Antioxidants, Vol. 11, Núm. 12
-
Olfactomedin 2 deficiency protects against diet-induced obesity
Metabolism: Clinical and Experimental, Vol. 129
-
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428
2020
-
SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production
Journal of Immunology, Vol. 205, Núm. 5, pp. 1198-1206